Hemostasis factors and aging

Experimental Gerontology

Volumn 43, Issue 2, 2008, Pages 66-73

  Mari, Daniela ^a   Coppola, Raffaella ^a   Provenzano, Rita ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Centenarians; Coagulation factors; Endothelial

Indexed keywords

ARGININE; BETA2 GLYCOPROTEIN 1; BIOLOGICAL MARKER; BLOOD CLOTTING FACTOR; BLOOD CLOTTING FACTOR 5; BLOOD CLOTTING FACTOR 8; COAGULASE; FIBRIN; FIBRINOGEN; GLUTAMINE; PHOSPHOLIPID ANTIBODY; PLASMINOGEN ACTIVATOR INHIBITOR 1; PROTEIN C; PROTEINASE; PROTHROMBIN; VON WILLEBRAND FACTOR;

AGING; ALLELE; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; ATHEROTHROMBOSIS; CORRELATION ANALYSIS; ENDOTHELIUM; ENZYME ACTIVITY; FIBRINOGEN BLOOD LEVEL; FIBRINOLYSIS; GENE MUTATION; GENETIC POLYMORPHISM; HEALTH STATUS; HEMOSTASIS; HIGH RISK POPULATION; HUMAN; HYPERCOAGULABILITY; LONGEVITY; PRIORITY JOURNAL; RISK FACTOR; SENESCENCE; SHORT SURVEY; THROMBOCYTE; THROMBOSIS; VEIN THROMBOSIS;

EID: 38149073315     PISSN: 05315565     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exger.2007.06.014     Document Type: Short Survey

References (54)

1. Abbate R., Prisco D., Rostagno C., Boddi M., and Gensini G.F. Age-related changes in the haemostatic system. Int. J. Clin. Lab. Res. 23 (1993) 1-3
2. Ariens R., Coppola R., Potenza I., and Mannucci P.M. The increase with age of the components of the tissue factor coagulation pathway is gender-dependent. Blood Coagul. Fibrinolysis 6 (1995) 433-437
3. Bajzar L., Jain N., Wang P., and Walker J.B. Thrombin activatable fibrinolysis inhibitor: not just an inhibitor of fibrinolysis. Crit. Care Med. 32 (2004) S320-S324
4. Balleisen L., Bailey J., Epping P.H., Schulte H., and van De Loo J. Epidemiological study on factor VII, factor VIII and fibrinogen in industrial population. Baseline data on the relation to age, gender, body-weight, smoking, alcohol, pill using and menopause. Thromb. Haemost. 54 (1985) 475-479
5. Bauer K.A., Weiss L.M., Sparrow D., Vokonas P.S., and Rosenberg R.D. Aging-associated changes in indices of thrombin generation and protein C activation in humans. Normative aging study. J. Clin. Invest. 80 (1987) 1527-1534
6. Bauer K.A., Kass B.L., Cate H.C., Hawiger J.J., and Rosenberg R.D. Factor IX is activated in vivo by the tissue factor mechanism. Blood 76 (1990) 731-736
7. Bladbjerg E.M., Andersen-Ranberg K., de Maat M.P.M., Kristensen S.R., Jeune B., Gram J., and Jespersen J. Longevity is independent of common variations in genes associated with cardiovascular risk. Thromb. Haemost. 82 (1999) 1110-1115
8. Bouma B.N., and Meijers J.C. New insights into factors affecting clot stability: a role for thrombin activatable fibrinolysis inhibitor (TAFI; plasma procarboxypeptidase B, plasma pro carboxypeptidase U, pro carboxypeptidase R). Semin. Hematol. 41 (2004) 13-19
9. Brandes R.P., Fleming I., and Busse R. Endothelial aging. Cardiovasc. Res. 66 (2005) 286-294
10. Cadroy Y., Daviau P., Saivin S., Sie P., and Boneu B. Distribution of 16 haemostatic laboratory variables assayed in 100 blood donors. Nouv. Rev. Fr. Hematol. 32 (1990) 259-264
11. Cadroy Y., Pierrejan D., Fontan B., Sie P., and Boneu B. Influence of aging on the activity of haemostatic system: prothrombin fragment 1+2, thrombin-antithrombin complexes and D-dimer in 80 healthy subjects with age ranging from 20 to 94 years. Nouv. Rev. Fr. Hematol. 34 (1992) 43-46
12. Celermajer D.S., Sorensen K.E., Spiegelhalter D.J., Georgakopoulos D., Robinson J., and Deanfield J.E. Aging is associated with endothelial dysfunction in healthy men years before the age-related decline in women. J. Am. Coll. Cardiol. 24 (1994) 471-476
13. Cesari M., Kritchevsky S.B., Leeuwenburgh C., and Pahor M. Oxidative damage and platelet activation as new predictors of mobility disability and mortality in elders. Antioxid. Redox Signal. 8 (2006) 609-619
14. Conlan M.G., Folsom A.R., Finch A., Davis C.E., Sorlie P., Marcucci G., and Wu K.K. Associations of factor VIII and von Willebrand factor with age, race, sex, and risk factors for atherosclerosis. The Atherosclerosis Risk in Communities (ARIC) Study. Thromb. Haemost. 70 (1993) 380-385
15. Conway D.S.G., Heeringa J., Van Der Kuip, Chin B.S.P., Hofman A., Witteman J.C.M., and Lip G.Y.H. Atrial fibrillation and the prothrombotic state in the elderly the Rotterdam study. Stroke 34 (2003) 413-417
16. Coppola R., Cristilli P., Cugno M., Ariens R.A., Mari D., and Mannucci P.M. Measurement of activated factor XII in health and disease. Blood Coagul. Fibrinolysis 7 (1996) 530-535
17. Coppola R., Mari D., Lattuada A., and Franceschi C. Von Willebrand factor in Italian centenarians. Haematologica 88 (2003) 39-43
18. Dolan G., Neal K., Cooper P., Brown P., Preston F.E., Protein C, antithrombin III and plasminogen. Effect of age, and sex and blood group. Br. J. Haematol. 86 (1994) 798-803
19. Ershler WB. Interleukin-6: a cytokine for gerontologists. .J Am. Geriatr. Soc. 41 (1993) 176-181
20. Faure-Delanef L., Quéré I., Zouali H., and Cohen D. Human longevity and R506Q factor V gene mutation. Thromb. Haemost. 78 (1997) 1160
21. Folsom A.R., Wu K.W., Rosamond W.D., Sharrett A.R., and Chambless L.E. Prospective study of hemostatic factors and incidence of coronary heart disease. The atherosclerosis risk in communities (ARIC) study. Circulation 96 (1997) 1102-1108
22. Frohlich M., Sund M., Russ S., Hoffmeister A., Fischer H.G., Hombach V., and Koenig W. Seasonal variations of rheological and hemostatic parameters and acute-phase reactants in young, healthy subjects. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 2692-2697
23. Kannel W.B., Wolf P.A., Castelli W.P., and D'Agostino R.B. Fibrinogen and risk of cardiovascular disease. The Framingham study. JAMA 258 (1987) 1183-1186
24. Kohler H.P., Carter A.M., Strickland M.H., and Grant P.J. Levels of activated FXII in survivors of myocardial infarction: association with circulating risk factors and extent of coronary artery disease. Thromb. Haemost. 79 (1998) 14-18
25. Kosaka T., Yamaguchi M., Miyanaga K., and Mizuno K. Serum platelet-activating factor acetylhydrolase (PAF-AH) activity in more than 3000 healthy Japanese. Clin. Chim. Acta 312 (2001) 179-183
26. Kristensen S.R., Andersen-Ranberg K., Bathum L., and Jeune B. Factor V Leiden and venous thrombosis in Danish centenarians. Thromb. Haemost. 80 (1998) 860-861
27. MacCallum P.K., and Meade T.W. Haemostatic function, arterial disease and the prevention of arterial thrombosis. Baillère's Clinical Haematology 12. N.3 (1999), Harcourt Publishers Ltd 577-579
28. Mannucci P.M., and Viganò S. Deficiencies of Protein C, an inhibitor of blood coagulation. Lancet ii (1982) 463-466
29. Mannucci P.M., Mari D., Merati G., Tagliabue L., Sacchi E., Taioli E., Sansoni P., Bertolini S., and Franceschi C. Gene polymorphisms predicting high plasma levels of coagulation and fibrinolysis proteins. A study in centenarians. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 759-775
30. Maresca G., Di Blasio A., Marchioli R., and Di Minno G. Measuring plasma fibrinogen to predict stroke and myocardial infarction. An update. Arterioscleros. Thromb. Vascular. Biol. 19 (1999) 1368-1377
31. Mari D., Mannucci P.M., Coppola R., Bottasso B., Bauer K.A., and Rosenberg R.D. Hypercoagulability in centenarians: the paradox of successful aging. Blood 85 (1995) 3144-3149
32. Mari D., Duca F., Mannucci P.M., and Franceschi C. Mutant factor V (Arg506Gln) in healthy centenarians. Lancet 347 (1996) 1044
33. Mari D., Parnetti L., Coppola R., Bottasso B., Reboldi G.P., Senin U., and Mannucci P.M. Hemostasis abnormalities in patient with vascular dementia and Alzheimer's disease. Thromb. Haemost. 75 (1996) 216-218
34. Matz R., and Andriantsitohaina R. Age-related endothelial dysfunction: potential implications for pharmacotherapy. Drugs Aging 20 (2003) 527-550
35. Meade T.W., North W.R.S., Chakrabarti R., Haines A.P., and Stirling Y. Population-based distributions of haemostatic variables. Br. Med. Bull. 33 (1977) 283-288
36. Meade T.W., Chakrabarti R., Haines A.P., North W.R.S., and Stirling Y. Characteristic affecting fibrinolytic activity and plasma fibrinogen concentration. Br. Med. J. 1 (1979) 153-156
37. Meade T.W., Chakrabarti R., Haines A.P., North Y., Thompson S.G., and Brozovic M. Haemostatic function and cardiovascular death. Early results of a prospective study. Lancet I (1980) 1050-1055
38. Meroni P.L., Mari D., Monti D., Coppola R., Capri M., Salvioli S., Tincani A., Gerli R., and Franceschi C. Anti-beta 2 glycoprotein I antibodies in centenarians. Exp. Gerontol. 39 (2004) 1459-1465
39. Ofosu F.A., Craven S., Dewar L., Anvari N., Andrew M., and Blajchman M.A. Age-related changes in factor VII proteolysis in vivo. Br. J. Haematol. 94 (1996) 407-412
40. Pignatelli P., Pulcinelli F.M., Lenti L., Gazzaniga P.P., and Violi F. Vitamin E inhibits collagen-induced platelet activation by blunting hydrogen peroxide. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 2542-2547
41. Poort S.R., Rosendaal F.R., Reitsma P.H., and Bertina R.M. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis. Blood 88 (1996) 3698-3703
42. Reilly I.A., Doran J.B., Smith B., and FitzGerald G.A. Increased thromboxane biosynthesis in a human preparation of platelet activation: biochemical and functional consequences of selective inhibition of thromboxane synthase. Circulation 73 (1986) 1300-1309
43. Rizzo M.R., Ragno E., Barbieri M., De Lucia D., Manzella D., Tagliamonte M.R., Colaizzo D., Margaglione M., and Paolisso G. Elevated plasma activator inhibitor 1 is not related to insulin resistance and to gene polymorphism in healthy centenarians. Atherosclerosis 160 (2002) 385-390
44. Sacchi E., Duca F., Franceschi C., and Mari D. Prothrombin gene mutation (G20210A) in healthy centenarians. Thromb. Haemost. 81 (1999) 990-991
45. Scarabin P.Y., Bara L., Nicaud V., Cambou J.P., Arveiler D., Luc G., Evans A.E., and Cambien F. Seasonal variations of plasma fibrinogen in elderly people. Lancet 343 (1994) 975-976
46. Smith F.B., Lee A.J., Fowkes F.G., Price J.F., Rumley A., and Lowe G.D. Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh artery study. Arterioscler. Thromb. Vasc. Biol. 17 (1997) 3321-3325
47. Stout R.W., Crawford V.L., Mcdermott M.J., Rocks M.J., and Morris T.C. Seasonal changes in haemostatic factors in young and elderly subjects. Age Ageing 25 (1996) 256-258
48. Tracy R.P., Arnold A.M., Ettinger W., Fried L., Meilahn E., and Savage P. The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly: results from the cardiovascular health study. Arterioscler. Thromb. Vasc. Biol. 19 (1999) 1776-1783
49. Van der Boome J.G., de Maat M.P., Bots M.L., Hofman A., Kluft C., and Grobbee D.E. Seasonal variation in fibrinogen in the Rotterdam study. Thromb. Haemost. 78 (1997) 1059-1062
50. Yamamoto K., Takeshita K., Shimokawa T., Yi H., Isobe K., Loskutoff D.J., and Saito H. Plasminogen activator inhibitor-1 is a major stress regulated gene: implications for stress-induced thrombosis in aged individuals. Proc. Natl. Acad. Sci. USA 99 (2002) 890-895
51. Yamamoto K., Takeshita K., Kojima T., Takamatsu J., and Saito H. Aging and plasminogen activator inhibitor-1 (PAI-1) regulation: implication in the pathogenesis of thrombotic disorders in the elderly. Cardiovasc. Res. 66 (2005) 276-285
52. West M.D., Shay J.W., Wright W.E., and Linskens M.H. Altered expression of plasminogen activator and plasminogen activator inhibitor during cellular senescence. Exp. Gerontol. 31 (1996) 175-193
53. Weverling-Rijnsburger A.W., Blauw G.J., Lagaay A.M., Knook D.L., Meinders A.E., and Westendorp R.G. Total cholesterol and risk of mortality in the oldest old. Lancet 350 (1997) 1119-1123
54. Wilhelmsen L., Svardsudd K., Korsan-Bengsten K., Larsson B., Welin L., Tibblin G., and Fibrinogen as a risk factor for stroke and myocardial infarction. N. Engl. J. Med. 31 (1984) 501-505